Beckman Coulter Offers Stem Cell Monitoring System to Clinical Labs on Flow Cytometry System
Beckman Coulter, Inc. announced today its stemCXP system, a new software module for stem cell monitoring that will be available on the company’s FC 500 CXP flow cytometry system. The proprietary application, along with the previously announced tetraCXP system used for HIV monitoring, has been validated for in vitro diagnostic use.
“The FC500 CXP flow cytometer is quickly becoming the cornerstone for new, easy-to-use IVD applications,” said Bonnie Anderson, vice president of Beckman Coulter’s Translational Solutions Business Center. “Now, with both stemCXP and tetraCXP, we can provide a high level of automation and simplicity to clinical laboratories doing HIV and stem cell monitoring.”
The stemCXP system, comprised of stemCXP software for FC 500 flow cytometry systems with CXP software, Stem-Kit(TM) Reagents, quality control and standardization reagents, provides automated analysis of various blood cell populations. The stemCXP System is intended for in vitro diagnostic use to simultaneously identify and enumerate CD45+ and CD45+/CD34+ dual positive cell populations, key indicators found in the blood of leukemia and lymphoma patients. These indicators are instrumental in monitoring disease progression and effectiveness of therapy.
The FC 500 CXP flow cytometry system, introduced to the clinical market last year, brought Beckman Coulter’s award-winning FC 500 platform from the life science and clinical research segments into the clinical diagnostics laboratory. The system offers a Windows*-based interface along with laboratory information system (LIS) connectivity and expanded quality control functionality.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum — from systems biology and clinical research to laboratory diagnostics and point-of-care testing — Beckman Coulter’s 200,000 installed systems provide essential biomedical information to enhance health care around the world. The company, based in Fullerton, Calif., reported 2003 annual sales of $2.2 billion with 64 percent of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit http://www.beckmancoulter.com .
